The effects of MK-801, a noncompetitive NMDA receptor antagonist, on in vivo and in vitro binding of radioactive iodine ([ 123 I] or [ 125 I]) labeled -CIT [RTI-55, 3-(4-iodophenyl)tropane-2-carboxylic acid methyl ester] were investigated in rat brain. In the in vitro binding study, 10 pM of [ 12
Comparative in vivo study of iodine-123-labeled β-cit and nor-β-cit binding to serotonin transporters in rat brain
✍ Scribed by Liesbeth Reneman; Jan Booij; Jules Lavalaye; Kora De Bruin; Frederik A. De Wolff; Richard P. Koopmans; Johannes C. Stoof; Gerard J. Den Heeten
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 462 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0887-4476
No coin nor oath required. For personal study only.
✦ Synopsis
Both iodine-123-labeled -CIT (2-carbomethoxy-3-(4-iodophenyl)tropane) and nor--CIT (2-carbomethoxy-3-(4-iodophenyl)nortropane) have shown to be suitable radioligands for imaging serotonin (5-HT) transporters. [ 123 I]nor--CIT has the highest in vitro affinity for 5-HT transporters among -CIT analogs reported so far. However, no direct comparison-studies of these two radiotracers as to their in vivo binding to 5-HT transporters have been reported so far. Therefore, it is still unclear which of the two radiotracers is more suitable for single photon emisison computed tomograpy (SPECT) imaging of 5-HT transporters. The purpose of this study was to compare directly in a controlled design the in vivo [ 123 I]-CIT and [ 123 I]nor--CIT binding to 5-HT transporters under the same conditions in rats with the focus on brain kinetic characteristics by means of a two-compartment analysis. We observed that [ 123 I]-CIT has a higher binding potential and faster kinetics for 5-HT transporters than [ 123 I]nor--CIT, suggesting that [ 123 I]-CIT may be a more suitable radioligand than [ 123 I]nor--CIT for imaging 5-HT transporters with SPECT. Synapse 34:77-80, 1999.
📜 SIMILAR VOLUMES